Compile Data Set for Download or QSAR
maximum 50k data
Found 101 of ic50 data for polymerid = 50006699
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50078630(CHEMBL4296718)
Affinity DataIC50:  136nMAssay Description:Displacement of H3K14Ac from BAZ2B (unknown origin) preincubated for 30 mins with non-biotinylated peptide followed by addition of biotinylated pepti...More data for this Ligand-Target Pair
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148289(CHEMBL3770199)
Affinity DataIC50:  160nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50526963(CHEMBL4456922)
Affinity DataIC50:  316nMAssay Description:Inhibition of BAZ2A (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148270(CHEMBL3739699)
Affinity DataIC50:  400nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148290(CHEMBL3770277)
Affinity DataIC50:  550nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148334(CHEMBL3770214)
Affinity DataIC50:  580nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148281(CHEMBL3770847)
Affinity DataIC50:  720nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM310898(N,N-dimethyl-3-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]py...)
Affinity DataIC50:  880nMAssay Description:Binding affinity to human partial length BAZ2A expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM310898(N,N-dimethyl-3-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]py...)
Affinity DataIC50:  880nMAssay Description:Binding affinity to human partial length BAZ2A expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148371(CHEMBL3770738)
Affinity DataIC50:  890nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148282(CHEMBL3771216)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148280(CHEMBL3771080)
Affinity DataIC50:  1.10E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148279(CHEMBL3769753)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148283(CHEMBL3770155)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148278(CHEMBL3769588)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50364107(CHEMBL1950956)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148284(CHEMBL3770449)
Affinity DataIC50:  1.70E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148277(CHEMBL3770410)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148276(CHEMBL3770112)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148275(CHEMBL3769769)
Affinity DataIC50:  3.30E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601335(CHEMBL5178939)
Affinity DataIC50:  4.00E+3nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148288(CHEMBL3770493)
Affinity DataIC50:  4.10E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148287(CHEMBL3771370)
Affinity DataIC50:  4.10E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50526958(CHEMBL4459169)
Affinity DataIC50:  6.31E+3nMAssay Description:Inhibition of BAZ2A (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148274(CHEMBL3769490)
Affinity DataIC50:  7.20E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148273(CHEMBL3769417)
Affinity DataIC50:  8.60E+3nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50256397(CHEMBL4088466)
Affinity DataIC50:  1.00E+4nMAssay Description:Inhibition of human BAZ2A (M1792 to L1905 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM342597(N-[3-(3-methyl-4-oxo-4,5,6,7-tetrahydro-2H-isoindo...)
Affinity DataIC50:  1.00E+4nMAssay Description:Inhibition of human BAZ2A (M1792 to L1905 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50158624(CHEMBL3786012)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human BAZ2A (M1792 to L1905 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601334(CHEMBL5172246)
Affinity DataIC50:  1.06E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601332(CHEMBL5174553)
Affinity DataIC50:  1.09E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601341(CHEMBL5205271)
Affinity DataIC50:  1.10E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601322(CHEMBL5192710)
Affinity DataIC50:  1.10E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601319(CHEMBL5186561)
Affinity DataIC50:  1.14E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601320(CHEMBL5170762)
Affinity DataIC50:  1.18E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601318(CHEMBL5172147)
Affinity DataIC50:  1.25E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601331(CHEMBL5200427)
Affinity DataIC50:  1.26E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601328(CHEMBL5205483)
Affinity DataIC50:  1.29E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601327(CHEMBL5171471)
Affinity DataIC50:  1.31E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601343(CHEMBL5190134)
Affinity DataIC50:  1.40E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601337(CHEMBL5190709)
Affinity DataIC50:  1.41E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601340(CHEMBL5191503)
Affinity DataIC50:  2.20E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50526959(CHEMBL4522991)
Affinity DataIC50:  2.51E+4nMAssay Description:Inhibition of BAZ2A (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50526959(CHEMBL4522991)
Affinity DataIC50:  2.51E+4nMAssay Description:Inhibition of BAZ2A (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601323(CHEMBL5207551)
Affinity DataIC50:  2.92E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50148272(CHEMBL3770550)
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of recombinant His6-TEV fused human BAZ2A expressed in Escherichia coli incubated for 30 mins in presence of biotinylated peptide by alpha...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601339(CHEMBL5184671)
Affinity DataIC50:  3.13E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50028142(CHEMBL2177300)
Affinity DataIC50: <3.16E+4nMAssay Description:Inhibition of human BAZ2A by BROMOscan assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601290(CHEMBL5195335)
Affinity DataIC50:  3.32E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetBromodomain adjacent to zinc finger domain protein 2A(Homo sapiens (Human))
Cancer Research Uk Cancer Therapeutics Unit

Curated by ChEMBL
LigandPNGBDBM50601336(CHEMBL5179501)
Affinity DataIC50:  3.32E+4nMAssay Description:Inhibition of His6-tagged BAZ2A (unknown origin) (1796 to 1899 residues) using H3K(Ac)14 substrate by AlphaScreen assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
Displayed 1 to 50 (of 101 total ) | Next | Last >>
Jump to: